BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25597344)

  • 41. The relationship between intact PTH and biointact PTH (1-84) with bone and mineral metabolism in pre-dialysis chronic kidney disease (CKD).
    O'Flaherty D; Sankaralingam A; Scully P; Manghat P; Goldsmith D; Hampson G
    Clin Biochem; 2013 Oct; 46(15):1405-9. PubMed ID: 23830844
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Alkaline phosphatase isoenzymes in the serum of patients with renal insufficiency].
    Sánchez Navarro MR; Fernández-Conde ME; Blanco Martín S; Samaniego C
    An Med Interna; 2002 Sep; 19(9):449-52. PubMed ID: 12420628
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between bone turnover markers and bone mineral density in puberty and constitutional delay of growth and puberty.
    Doneray H; Orbak Z
    West Indian Med J; 2008 Jan; 57(1):33-9. PubMed ID: 19565936
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Restoration of parathyroid function after change of phosphate binder from calcium carbonate to lanthanum carbonate in hemodialysis patients with suppressed serum parathyroid hormone.
    Inaba M; Okuno S; Nagayama H; Yamada S; Ishimura E; Imanishi Y; Shoji S
    J Ren Nutr; 2015 Mar; 25(2):242-6. PubMed ID: 25556148
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Osteopathy in chronic kidney failure].
    Binswanger U; Fischer J; Schenk R; Merz W
    Dtsch Med Wochenschr; 1971 Dec; 96(49):1914-5 passim. PubMed ID: 5127025
    [No Abstract]   [Full Text] [Related]  

  • 46. Low parathyroid hormone status induced by high dialysate calcium is an independent risk factor for cardiovascular death in hemodialysis patients.
    Merle E; Roth H; London GM; Jean G; Hannedouche T; Bouchet JL; Drüeke T; Fouque D; Daugas E;
    Kidney Int; 2016 Mar; 89(3):666-74. PubMed ID: 26880460
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dietary phosphorus and kidney disease.
    Uribarri J
    Ann N Y Acad Sci; 2013 Oct; 1301():11-9. PubMed ID: 23876096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis?
    Avbersek-Luznik I; Balon BP; Rus I; Marc J
    Nephrol Dial Transplant; 2005 Mar; 20(3):566-70. PubMed ID: 15665031
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Review article: Chronic kidney disease-mineral bone disorder: have we got the assays right?
    Zidehsarai MP; Moe SM
    Nephrology (Carlton); 2009 Jun; 14(4):374-82. PubMed ID: 19563378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prevalence of pathologic vitamin D and parathyroid hormone levels in geriatric patients].
    Oster P; von Tabouillot W; Nold F; Schmidt-Gayk H; Schlierf G
    Aktuelle Gerontol; 1983 Nov; 13(6):221-2. PubMed ID: 6140873
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
    Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
    Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis.
    Yamada S; Tsuruya K; Yoshida H; Taniguchi M; Haruyama N; Tanaka S; Eriguchi M; Nakano T; Kitazono T
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):844-51. PubMed ID: 23078546
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Age- and sex-matched reference curves for serum collagen type I C-telopeptides and bone alkaline phosphatase in children and adolescents: An alternative multivariate statistical analysis approach.
    Gennai I; Di Iorgi N; Reggiardo G; Gatti C; Bertelli E; Allegri AE; Barco S; Maghnie M; Tripodi G; Cangemi G
    Clin Biochem; 2016 Jul; 49(10-11):802-7. PubMed ID: 27087512
    [No Abstract]   [Full Text] [Related]  

  • 54. Bisphosphonates prevent the hungry bone syndrome.
    Kumar A; Ralston SH
    Nephron; 1996; 74(4):729. PubMed ID: 8956310
    [No Abstract]   [Full Text] [Related]  

  • 55. Rebuttal: PTH--a particularly tricky hormone: why measure it at all in kidney patients?
    Sprague SM; Moe SM
    Clin J Am Soc Nephrol; 2013 Feb; 8(2):321. PubMed ID: 23160258
    [No Abstract]   [Full Text] [Related]  

  • 56. Cardiac physiopathology and alkaline phosphatase.
    Martins MJ; Azevedo I
    Pediatr Cardiol; 2009 Jan; 30(1):91. PubMed ID: 19048178
    [No Abstract]   [Full Text] [Related]  

  • 57. Need for better PTH assays for clinical research and patient treatment.
    Hocher B; Zeng S
    Clin Chem Lab Med; 2018 Jan; 56(2):183-185. PubMed ID: 28809750
    [No Abstract]   [Full Text] [Related]  

  • 58. Letter: Plasma biochemistry in haemodialysed patients.
    Bishop MC
    Lancet; 1973 Dec; 2(7841):1328-9. PubMed ID: 4127674
    [No Abstract]   [Full Text] [Related]  

  • 59. Rebuttal: the case for routine parathyroid hormone monitoring.
    Goldsmith DJ
    Clin J Am Soc Nephrol; 2013 Feb; 8(2):319-20. PubMed ID: 23160263
    [No Abstract]   [Full Text] [Related]  

  • 60. An improved autoanalyzer technique for the determination of serum alkaline phosphatase.
    Price CP; Woodman DD
    Clin Chim Acta; 1971 Dec; 35(2):265-71. PubMed ID: 5125312
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.